Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion type Assertion NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_head.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion evidence source_evidence_literature NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion SIO_000772 14507635 NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion wasDerivedFrom lhgdn-20090331 NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion wasGeneratedBy ECO_0000203 NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.